Training program for neuro-infectious diseases in Uganda
Official title: Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium
Funded at University of Minnesota · NIH-11173825 · Data updated 2026-11-12
This study is helping doctors in Uganda learn more about serious brain infections related to HIV, like cryptococcal meningitis and TB meningitis, so they can improve treatment and care for patients in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project start | August 14, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $248,400 |
| NIH project number | 5D43TW012266-02 |
| Project ID | NIH-11173825 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are healthcare professionals in Uganda who have completed their Master's of Medicine and are seeking further training in neuro-infectious diseases.
✕Less likely to help
Patients who are not healthcare professionals or those outside of the Sub-Saharan Africa region may not benefit directly from this research.
What this research studies
This research focuses on addressing central nervous system infections, particularly those related to HIV, such as cryptococcal meningitis and TB meningitis, which significantly impact health in Sub-Saharan Africa. The program aims to provide intensive training for Ugandan medical professionals in various fields including clinical research, biostatistics, and neurology. Participants will engage in mentored research experiences to enhance their skills, publish their findings, and prepare for advanced research opportunities. The initiative builds on a successful partnership that has already contributed to significant advancements in the field.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of neuro-infectious diseases, ultimately reducing mortality and morbidity in affected populations.
How similar studies have gone: Previous research initiatives in this area have shown success, with over 150 publications and several Ugandan researchers securing independent funding.
Where this research is happening
-
University of Minnesota
Minneapolis, United States Active
Researchers
- Principal investigator: Boulware, David R — University of Minnesota
- Study coordinator: Boulware, David R
Related research
Other NIH-funded projects on the same topics.
-
Latin American Center for Emerging Infectious Disease Surveillance and Readiness
A regional collaboration in Peru and neighboring countries aims to strengthen early warning and monitoring for viruses that could jump from animals to people, helping communities prepare for outbreaks.
-
Center in Latin America to monitor emerging infectious diseases
A U01 grant supporting a collaboration between Peruvian and U.S. researchers to improve early detection and surveillance of regionally relevant viruses that could affect people, animals, and crops in Peru and neighboring areas.
-
Acanthamoeba as a modern model parasite to study infectious disease biology and mitochondria
A five-year project will define the mitochondrial proteins and pathways of Acanthamoeba castellanii to advance infectious disease biology and parasite metabolism.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
-
Multi-omic endotypes of vaccine response, respiratory infections, and asthma in children
A parent-friendly look at how early-life immune development shapes how kids respond to vaccines and stay free from lung infections and asthma, using advanced biological profiling.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.